These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 34126912)

  • 21. Synthesis and in vitro investigation of novel cytotoxic pyrimidine and pyrazolopyrimidne derivatives showing apoptotic effect.
    Ragab FA; Nissan YM; Seif EM; Maher A; Arafa RK
    Bioorg Chem; 2020 Mar; 96():103621. PubMed ID: 32036162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, Synthesis, and Antiproliferative Activity of Quinazolin-4-One/Chalcone Hybrids
    Hisham M; Hassan HA; Gomaa HAM; Youssif BGM; Hayalah AM; Abdel-Aziz M
    Anticancer Agents Med Chem; 2023; 23(17):1932-1943. PubMed ID: 37497685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
    Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
    Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New pyranopyrazole based derivatives: Design, synthesis, and biological evaluation as potential topoisomerase II inhibitors, apoptotic inducers, and antiproliferative agents.
    Sobh EA; Kassab AE; El-Khouly EA; S A Hassan M
    Bioorg Chem; 2024 Mar; 144():107158. PubMed ID: 38301427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N- and s-substituted Pyrazolopyrimidines: A promising new class of potent c-Src kinase inhibitors with prominent antitumor activity.
    Awaji AA; Zaloa WAZE; Seleem MA; Alswah M; Elsebaei MM; Bayoumi AH; El-Morsy AM; Alfaifi MY; Shati AA; Elbehairi SEI; Almaghrabi M; Aljohani AKB; Ahmed HEA
    Bioorg Chem; 2024 Apr; 145():107228. PubMed ID: 38422592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and anticancer activity of some pyrido[2,3-
    Abbas SE; George RF; Samir EM; Aref MM; Abdel-Aziz HA
    Future Med Chem; 2019 Sep; 11(18):2395-2414. PubMed ID: 31544523
    [No Abstract]   [Full Text] [Related]  

  • 27. Novel 1,2,4-triazole derivatives as apoptotic inducers targeting p53: Synthesis and antiproliferative activity.
    Gomaa HAM; El-Sherief HAM; Hussein S; Gouda AM; Salem OIA; Alharbi KS; Hayallah AM; Youssif BGM
    Bioorg Chem; 2020 Dec; 105():104369. PubMed ID: 33091670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and biological evaluation of certain CDK2 inhibitors based on pyrazole and pyrazolo[1,5-a] pyrimidine scaffold with apoptotic activity.
    Ali GME; Ibrahim DA; Elmetwali AM; Ismail NSM
    Bioorg Chem; 2019 May; 86():1-14. PubMed ID: 30682722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, biological evaluation, and in silico studies of indole-tethered pyrazoline derivatives as anticancer agents targeting topoisomerase IIα.
    Haider K; Sharma S; Pokharel YR; Das S; Joseph A; Najmi AK; Ahmad F; Yar MS
    Drug Dev Res; 2022 Nov; 83(7):1555-1577. PubMed ID: 35898169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of novel α-aminophosphonate oxadiazoles via optimized iron triflate catalyzed reaction as apoptotic inducers.
    Ewies EF; El-Hussieny M; El-Sayed NF; Fouad MA
    Eur J Med Chem; 2019 Oct; 180():310-320. PubMed ID: 31323616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An investigative study of antitumor properties of a novel thiazolo[4,5-d]pyrimidine small molecule revealing superior antitumor activity with CDK1 selectivity and potent pro-apoptotic properties.
    Mohamed SH; Elgiushy HR; Taha H; Hammad SF; Abou-Taleb NA; A M Abouzid K; Al-Sawaf H; Hassan Z
    Bioorg Med Chem; 2020 Sep; 28(17):115633. PubMed ID: 32773088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines.
    Safwat GM; Hassanin KMA; Mohammed ET; Ahmed EK; Abdel Rheim MR; Ameen MA; Abdel-Aziz M; Gouda AM; Peluso I; Almeer R; Abdel-Daim MM; Abdel-Wahab A
    Oxid Med Cell Longev; 2021; 2021():4759821. PubMed ID: 35003514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure-activity relationship and biological activity as potential antitumor and anticonvulsant agents.
    Lamie PF; El-Kalaawy AM; Abdel Latif NS; Rashed LA; Philoppes JN
    Eur J Med Chem; 2021 Mar; 214():113222. PubMed ID: 33545637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives.
    Alkamaly OM; Altwaijry N; Sabour R; Harras MF
    Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000351. PubMed ID: 33252142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors.
    Sayed AM; Taher FA; Abdel-Samad MRK; El-Gaby MSA; El-Adl K; Saleh NM
    Bioorg Chem; 2021 Mar; 108():104669. PubMed ID: 33515863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiproliferative activity, enzymatic inhibition and apoptosis-promoting effects of benzoxazole-based hybrids on human breast cancer cells.
    Omar AME; AboulWafa OM; Amr ME; El-Shoukrofy MS
    Bioorg Chem; 2021 Apr; 109():104752. PubMed ID: 33657444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,3,4-Thiadiazolo (3,2-Α) Pyrimidine-6-Carbonitrile Scaffold as PARP1 Inhibitors.
    Kaviarasan L; Eldhose E; Krishnamurthy PT; Rajagopal K; Mohammed M; Prudviraj P; Byran G
    Anticancer Agents Med Chem; 2021; 21(15):2050-2065. PubMed ID: 33327923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and antitumor evaluation of novel 5-methylpyrazolo[1,5-a]pyrimidine derivatives as potential c-Met inhibitors.
    Luo G; Ma Y; Liang X; Xie G; Luo Y; Zha D; Wang S; Yu L; Zheng X; Wu W; Zhang C
    Bioorg Chem; 2020 Nov; 104():104356. PubMed ID: 33142417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Approaches for the Synthesis N-alkylated Benzo[
    El-Sharkawy KA; Mohamed AA; Al Farouk FO; Mohareb RM
    Anticancer Agents Med Chem; 2023; 23(12):1429-1446. PubMed ID: 36927433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.